Covered recipient · General Payments record
KHATUNA N STEPKOVITCH
Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine
General Payments · PY2021–2025
$1,430.05
- Reported across 56 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $252.81 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $87.94 | 3 |
| Neurocrine BioSciences, Inc. | $31.24 | 1 |
| Janssen Pharmaceuticals, Inc | $28.54 | 1 |
| Corcept Therapeutics | $24.88 | 1 |
| Exact Sciences Corporation | $24.51 | 1 |
| Lilly USA, LLC | $19.19 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.49 | 1 |
| Axsome Therapeutics, Inc. | $18.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.35 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204407658 | CMS |
| ABBVIE INC. | $28.08 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204407661 | CMS |
| ABBVIE INC. | $26.51 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204407665 | CMS |
| Axsome Therapeutics, Inc. | $18.02 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235737323 | CMS |
| Corcept Therapeutics | $24.88 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214176130 | CMS |
| Exact Sciences Corporation | $24.51 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235642798 | CMS |
| Janssen Pharmaceuticals, Inc | $28.54 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174716808 | CMS |
| Lilly USA, LLC | $19.19 | 09/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186709265 | CMS |
| Neurocrine BioSciences, Inc. | $31.24 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242985209 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.49 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223844639 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.